Literature DB >> 33602276

Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome.

Juan Du1, Xiangyan Ruan2,3, Fengyu Jin1, Yanglu Li1, Jiaojiao Cheng1, Muqing Gu1, Alfred Otto Mueck1,4.   

Abstract

PURPOSE: To investigate abnormalities of early folliculogenesis and Anti-Müllerian hormone (AMH) concentrations in polycystic ovary syndrome (PCOS) patients, and to analyze the association between AMH and early-stage follicle densities (FD).
METHODS: A total of 175 patients underwent ovarian tissue cryopreservation in the first official cryobank in China, of which 16 patients aged 30-40 years old were diagnosed with endometrial cancer (all without initial chemo/radiotherapy), including 5 patients with concurrent PCOS and the other 11 patients without. We obtained standard cortical biopsies to measure FD using calcein staining. Blood samples were collected before cryopreservation to evaluate AMH concentrations.
RESULTS: PCOS showed nearly three times the primordial and primary FD than NPCOS (P = 0.027), as well as more secondary preantral follicles (P = 0.002). A significantly higher proportion of secondary preantral follicles and a lower proportion of primordial and primary follicles were observed in PCOS (P = 0.01). Furthermore, the AMH concentration in PCOS was four times higher than that in NPCOS (P = 0.003), which is significantly correlated with primordial and primary follicle densities (r = 0.855, P < 0.001) and secondary preantral follicle densities (r = 0.732, P = 0.007).
CONCLUSIONS: We found significant disorders of early folliculogenesis in PCOS, which showed close correlation with increased AMH concentrations. To our knowledge, abnormalities of early-stage follicles have been shown for the first time in ovarian tissue of Chinese PCOS women. We suppose that the elevated AMH level is associated with abnormalities of early folliculogenesis within the complex PCOS pathogenesis, which may explain why AMH has the potential to be used as a biomarker for the diagnosis of PCOS. Our findings provide more implications for understanding the mechanism of PCOS, and new directions for further studies.

Entities:  

Keywords:  AMH; Early folliculogenesis; Follicle density; PCOS

Year:  2021        PMID: 33602276      PMCID: PMC7893904          DOI: 10.1186/s13048-021-00786-0

Source DB:  PubMed          Journal:  J Ovarian Res        ISSN: 1757-2215            Impact factor:   4.234


  29 in total

Review 1.  Ovarian Folliculogenesis.

Authors:  Nitzan Rimon-Dahari; Lia Yerushalmi-Heinemann; Liat Alyagor; Nava Dekel
Journal:  Results Probl Cell Differ       Date:  2016

2.  Premature progesterone rise as a trigger of polycystic ovarian syndrome.

Authors:  Dmitri I Dozortsev; Antonio Pellicer; Michael P Diamond
Journal:  Fertil Steril       Date:  2020-10-06       Impact factor: 7.329

3.  Serum anti-Müllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China.

Authors:  Xuanxuan Tian; Xiangyan Ruan; Alfred O Mueck; Diethelm Wallwiener; Juan Wang; Shunyu Liu; Dongmei Yin; Yongjun Lu; Ying Zhang; Hongqin Wu
Journal:  Gynecol Endocrinol       Date:  2014-07-21       Impact factor: 2.260

Review 4.  Disordered follicle development.

Authors:  R Jeffrey Chang; Heidi Cook-Andersen
Journal:  Mol Cell Endocrinol       Date:  2012-07-31       Impact factor: 4.102

Review 5.  Genetic determinants of polycystic ovary syndrome: progress and future directions.

Authors:  Michelle R Jones; Mark O Goodarzi
Journal:  Fertil Steril       Date:  2016-05-11       Impact factor: 7.329

Review 6.  Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.

Authors:  Didier Dewailly; Geoffroy Robin; Maëliss Peigne; Christine Decanter; Pascal Pigny; Sophie Catteau-Jonard
Journal:  Hum Reprod Update       Date:  2016-08-27       Impact factor: 15.610

Review 7.  The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility.

Authors:  Jure Bedenk; Eda Vrtačnik-Bokal; Irma Virant-Klun
Journal:  J Assist Reprod Genet       Date:  2019-11-21       Impact factor: 3.412

8.  Anti-Müllerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China.

Authors:  Xuanxuan Tian; Xiangyan Ruan; Alfred O Mueck; Juan Wang; Shunyu Liu; Dongmei Yin; Yongjun Lu; Hongqin Wu; Ying Zhang
Journal:  Gynecol Endocrinol       Date:  2013-12-04       Impact factor: 2.260

9.  Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO.

Authors:  Stine Gry Kristensen; Ajay Kumar; Bhanu Kalra; Susanne Elisabeth Pors; Jane Alrø Bøtkjær; Linn Salto Mamsen; Lotte Berdiin Colmorn; Jens Fedder; Erik Ernst; Lisa Ann Owens; Kate Hardy; Stephen Franks; Claus Yding Andersen
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

10.  Randomized study to prove the quality of human ovarian tissue cryopreservation by xenotransplantation into mice.

Authors:  Xiangyan Ruan; Yamei Cui; Juan Du; Jing Jin; Muqing Gu; Suwen Chen; Alfred O Mueck
Journal:  J Ovarian Res       Date:  2019-05-21       Impact factor: 4.234

View more
  2 in total

1.  A Systematic Review of Ovarian Tissue Transplantation Outcomes by Ovarian Tissue Processing Size for Cryopreservation.

Authors:  Ashley A Diaz; Hana Kubo; Nicole Handa; Maria Hanna; Monica M Laronda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

2.  The Relationship between Ovarian Ultrasound Parameters and Endocrine and Metabolic Indicators in Patients with Ovarian Syndrome.

Authors:  Changqing Sheng; Jin Zhang; Jiang Jue
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-30       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.